Compare DAKT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAKT | EVO |
|---|---|---|
| Founded | 1968 | 1993 |
| Country | United States | Germany |
| Employees | 2702 | 4553 |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.0M | 934.1M |
| IPO Year | 1996 | N/A |
| Metric | DAKT | EVO |
|---|---|---|
| Price | $19.54 | $2.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 243.0K | 91.4K |
| Earning Date | 03-04-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $608,932,000.00 | N/A |
| Revenue This Year | $12.06 | $1.37 |
| Revenue Next Year | $9.16 | $10.05 |
| P/E Ratio | $25.40 | ★ N/A |
| Revenue Growth | ★ 6.89 | N/A |
| 52 Week Low | $13.05 | $2.31 |
| 52 Week High | $28.27 | $4.80 |
| Indicator | DAKT | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 46.76 | 46.32 |
| Support Level | $18.99 | $2.63 |
| Resistance Level | $20.40 | $3.78 |
| Average True Range (ATR) | 0.56 | 0.09 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 33.50 | 33.38 |
Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.